Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ALLO-316
i
Other names:
ALLO-316, anti-CD70 AlloCAR T, ALLO316, ALLO 316
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Allogene Therap, Cellectis
Drug class:
CD70-targeted CAR-T immunotherapy
Related drugs:
‹
8R-70CAR T (0)
CD70 CAR-T (0)
CD70 CAR-T (0)
CD70-directed CAR-T (0)
CTX130 (0)
CTX131 (0)
multi-CAR-T cell therapy (0)
8R-70CAR T (0)
CD70 CAR-T (0)
CD70 CAR-T (0)
CD70-directed CAR-T (0)
CTX130 (0)
CTX131 (0)
multi-CAR-T cell therapy (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
ALLO-316
Sensitive: B - Late Trials
ALLO-316
Sensitive
:
B
ALLO-316
Sensitive: B - Late Trials
ALLO-316
Sensitive
:
B
CD70 expression
Acute Myelogenous Leukemia
CD70 expression
Acute Myelogenous Leukemia
ALLO-316
Sensitive: D – Preclinical
ALLO-316
Sensitive
:
D
ALLO-316
Sensitive: D – Preclinical
ALLO-316
Sensitive
:
D
CD70 expression
Renal Cell Carcinoma
CD70 expression
Renal Cell Carcinoma
ALLO-316
Sensitive: D – Preclinical
ALLO-316
Sensitive
:
D
ALLO-316
Sensitive: D – Preclinical
ALLO-316
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login